Abstract
Duck viral hepatitis (DVH) is an acute, highly contagious, viral disease of young ducklings , usually <6 weeks of age, and is characterized by liver lesions and opisthotonos. , In order to control DVH, the AHRI developed a DVH active immunization vaccine and a passive hyperserum to effectively prevent the occurrence of DVH. In 2015, we conducted field trials of our developed duck viral hepatitis vaccine. The results showed that this vaccine is both safe and efficacious, and that the duck egg antibodies reach the national inspection standards (NI>3.0) after immunization. The value of this egg yolk antibody product was assessed in order to determine the potential for future technology transfer opportunities and additionally, one batch was produced for national inspection. In conclusion, AHRI demonstrated its capabilities in combating the occurrence of duck viral hepatitis in the future.
|
Abstract
Duck viral hepatitis (DVH) is an important disease affecting waterfowl, causing significant annual economic losses worldwide. The Animal Health Research Institute (AHRI) plans to apply for the establishment of a World Organization for Animal Health (OIE)’s reference laboratory, specifically focused on DVH. There is currently no OIE reference laboratory for the study of DVH in the world. The Poultry Institute of the Chinese Academy of Agricultural Sciences and the College of Veterinary Medicine of the China Agricultural University are all important institutes actively researching waterfowl diseases. Research fellow Tseng Chun-hsein and assistant researcher Shih Yu-hua were dispatched to visit these institutes in China. Critical insight regarding waterfowl diseases outbreaks was gained and the invaluable exchange of technical knowledge was also achieved. In conclusion, based on the research experience and technical exchange attained at these two poultry disease research institutes, we were able to assess the occurrence of international pandemic situations of DVH as well as foster further international cooperation. We believe initiatives such as these will be invaluable for the application of an OIE reference laboratory and for future vaccine development projects.
|